Lifeward (LFWD) Share-based Compensation (2015 - 2026)
Lifeward (LFWD) reported Share-based Compensation of $177000.0 for Q1 2026, down 19.55% on a YoY basis from $220000.0 in Q1 2025, and down 79.39% sequentially from $859000.0 in Q4 2025.
Lifeward (LFWD) Share-based Compensation (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 11 years of Share-based Compensation data on file, last reported at $177000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 19.55% year-over-year to $177000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 4250.0% YoY), and the FY2025 full-year result was $1.4 million, up 643.52% from the prior year.
- Share-based Compensation declined to $177000.0 in Q1 2026, from $859000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $859000.0 in Q4 2025 to a low of -$854000.0 in Q4 2024.
- A 4-year average of $231800.0 and a median of $255000.0 in 2024 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 200.59% in 2025, while the deepest fall reached 51.6% in 2025.
- Tracing LFWD's Share-based Compensation over 4 years: stood at $513000.0 in 2023, then sank by 266.47% to -$854000.0 in 2024, then surged by 200.59% to $859000.0 in 2025, then slumped by 79.39% to $177000.0 in 2026.
- Business Quant data shows LFWD's Share-based Compensation at $177000.0 in Q1 2026, $859000.0 in Q4 2025, and $174000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 177,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 177,000.00 |
| Mar 31, 2026 | 177,000.00 |
| Dec 31, 2025 | 859,000.00 |
| Dec 31, 2025 | 859,000.00 |
| Sep 30, 2025 | 174,000.00 |
| Sep 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Dec 31, 2024 | -854,000.00 |
| Dec 31, 2024 | -854,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 381,000.00 |
| Mar 31, 2024 | 381,000.00 |
| Mar 31, 2023 | 513,000.00 |
| Mar 31, 2023 | 513,000.00 |